Vertex says FDA accepted suzetrigine new drug application

Vertex Pharmaceuticals announced that the Food and Drug Administration has accepted its new drug application submission for suzetrigine, an investigational, oral, selective NaV1.8 pain signal inhibitor to treat moderate-to-severe acute [...]